Winston-Salem’s Plakous Therapeutics lands $1.7M fast-track SBIR grant
Plakous is developing human placenta-derived regenerative therapies, initially focused on Protego-PD, a platform product to treat a devastating and costly disease of premature babies called necrotizing enterocolitis (NEC).
Read More
